TLDR Low-dose oral minoxidil significantly improves hair density in non-scarring alopecia.
This retrospective study evaluated the effectiveness of low-dose oral minoxidil (LDOM) in treating non-scarring alopecias, specifically androgenetic alopecia and telogen effluvium, in 60 patients. Using AI-powered HairMetrix imaging, the study observed significant improvements in hair density over a period of 4-8 months. The findings highlight the potential of LDOM to improve hair density in real-world settings, utilizing a standardized and non-invasive imaging method to quantify treatment response.
April 2025 in “Acta Dermato Venereologica” Accurate diagnosis is crucial to distinguish between allergy and irritation from topical minoxidil.
March 2025 in “Journal of the American Academy of Dermatology” Systemic minoxidil improves hair density in women with female pattern hair loss over time.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
February 2024 in “Cosmoderma” Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.
February 2020 in “The Pharmaceutical Society of Japan” 8 citations
,
March 2015 in “PubMed” 5% minoxidil foam effectively treats female hair loss.
January 2007 in “Strait Pharmaceutical Journal” 
1 citations
,
September 2002 in “PubMed” Minoxidil helps stimulate hair growth and reduce hair loss in women with androgenic alopecia.
370 citations
,
September 1999 in “The New England Journal of Medicine” Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.
